WOMEN’S ROGAINE (minoxidil) Johnson and johnson Patent: 6,946,120 Expiration: Apr 20, 2019 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact…
Posts published in “Patent Expiration”
MEN’S ROGAINE (minoxidil) Johnson and johnson Patent: 6,946,120 Expiration: Apr 20, 2019 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact…
Annual Drug Patent Expirations for FLECTOR Flector is a drug marketed by Inst Biochem and is included in one NDA. It is available from eleven suppliers. There is one patent…
Annual Drug Patent Expirations for PRILOSEC Prilosec is a drug marketed by Astrazeneca Pharms and Covis Pharma Bv and is included in three NDAs. It is available from three suppliers.…
Annual Drug Patent Expirations for NEXIUM Nexium is a drug marketed by Astrazeneca Pharms and Astrazeneca Lp and is included in six NDAs. It is available from seven suppliers. There…
Annual Drug Patent Expirations for TUXARIN+ER Tuxarin Er is a drug marketed by Mainpointe and is included in one NDA. It is available from two suppliers. There are four patents…
Annual Drug Patent Expirations for NORETHINDRONE+AND+ETHINYL+ESTRADIOL+AND+FERROUS+FUMARATE Norethindrone And Ethinyl Estradiol And Ferrous Fumarate is a drug marketed by Accord Hlthcare, Amneal Pharms, Apil, Barr, Lupin Ltd, and Mylan Labs Ltd…
Annual Drug Patent Expirations for MINASTRIN+24+FE Minastrin 24 Fe is a drug marketed by Apil and is included in one NDA. It is available from two suppliers. There is one…
Annual Drug Patent Expirations for FEMCON+FE Femcon Fe is a drug marketed by Apil and is included in one NDA. It is available from two suppliers. There is one patent…
Annual Drug Patent Expirations for LO+MINASTRIN+FE Lo Minastrin Fe is a drug marketed by Apil and is included in one NDA. It is available from one supplier. There are two…